These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15043758)

  • 21. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
    Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
    Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
    Covach A; Patel S; Hardin H; Lloyd RV
    Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of molecular expression profiles of Hürthle cell tumors of the thyroid gland analyzed via tissue microarrays.
    Hoos A; Stojadinovic A; Singh B; Dudas ME; Leung DH; Shaha AR; Shah JP; Brennan MF; Cordon-Cardo C; Ghossein R
    Am J Pathol; 2002 Jan; 160(1):175-83. PubMed ID: 11786411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.
    Chiappetta G; Toti P; Cetta F; Giuliano A; Pentimalli F; Amendola I; Lazzi S; Monaco M; Mazzuchelli L; Tosi P; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):364-9. PubMed ID: 11788677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
    Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
    Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine-needle aspiration biopsies in the management of indeterminate follicular and Hurthle cell thyroid lesions.
    Mijović T; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Payne RJ
    Otolaryngol Head Neck Surg; 2009 May; 140(5):715-9. PubMed ID: 19393417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follicular and Hürthle cell carcinoma of the thyroid gland.
    Phitayakorn R; McHenry CR
    Surg Oncol Clin N Am; 2006 Jul; 15(3):603-23, ix-x. PubMed ID: 16882500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytochemical expression of Ki67 and laminin in Hurthle cell adenomas and carcinomas.
    Pisani T; Pantellini F; Centanni M; Vecchione A; Giovagnoli MR
    Anticancer Res; 2003; 23(4):3323-6. PubMed ID: 12926070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
    Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
    Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hurthle cell neoplasm: our experience].
    Cristofaro MG; Vescio G; Fava MG; Aversa C; Amantea M; Giudice M
    Ann Ital Chir; 2004; 75(6):663-8. PubMed ID: 15960361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
    Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
    Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
    Nikiforova MN; Biddinger PW; Caudill CM; Kroll TG; Nikiforov YE
    Am J Surg Pathol; 2002 Aug; 26(8):1016-23. PubMed ID: 12170088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite instability in thyroid tumours and tumour-like lesions.
    Lazzereschi D; Palmirotta R; Ranieri A; Ottini L; Verì MC; Cama A; Cetta F; Nardi F; Colletta G; Mariani-Costantini R
    Br J Cancer; 1999 Jan; 79(2):340-5. PubMed ID: 9888478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
    Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.
    Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L
    J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer.
    Liska J; Altanerova V; Galbavy S; Stvrtina S; Brtko J
    Endocr Regul; 2005 Sep; 39(3):73-83. PubMed ID: 16468229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
    Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
    Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria.
    Renshaw AA
    Cancer; 2002 Oct; 96(5):261-6. PubMed ID: 12378592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.